Vertex Pharma (VRTX) Posts Q3 Loss of 32c/Share; Will Cut Workforce, Refocus on CF

October 29, 2013 8:06 AM

Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX) reported Q3 EPS of ($0.32), $0.01 worse than the analyst estimate of ($0.31). Revenue for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found